Seeking Alpha

NuVasive (NUVA +5.6%) gets a pop from an upgrade to Outperform at RBC Capital. The firm says...

NuVasive (NUVA +5.6%) gets a pop from an upgrade to Outperform at RBC Capital. The firm says that the results of a recent survey of U.S. spine surgeons show the Street may be underestimating the near-term sustainability of the medical device company's U.S. lumbar revenue growth rate.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)